OpenAI Offers US University Labs Free GPT-Rosalind Access

Oct 15, 2026
OpenAI's Rosalind Academic Plan gives eligible US university biology labs up to 30 sponsored seats for one year, including access to GPT-Rosalind.

OpenAI is offering eligible US university biology labs sponsored access to GPT-Rosalind through its Rosalind Academic Plan, according to Crypto Briefing. Principal investigators and lab leaders can receive up to 30 Business Standard seats for 12 months.

The seats include GPT-Rosalind and other advanced OpenAI models. Research data from participating accounts will not be used to train OpenAI models by default. Labs must receive organizational approval, and access is limited to eligible scientific research.

GPT-Rosalind can analyze biological entities, summarize scientific literature, plan experiments and connect with scientific databases. OpenAI initially released the model through a research preview on April 16, 2026.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.